Form D · Biotechnology

PROTHERA BIOLOGICS, INC.

Providence, RI · CIK 0001659513

Offering snapshot reported Jan 8, 2019 · SEC filing

Reported sold
$750K
Offering amount: $2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jan 3, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$375K$750KJan 10, 2018: $250,000.00Jan 10, 2018Jan 8, 2019: $750,000.00Jan 8, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$250,000 → $750,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 8, 2019Amendment$750,000$500,000vs Jan 10, 20181SEC filing
Jan 10, 2018Initial$250,000No comparison1SEC filing
Dec 1, 2015Initial$1No comparison1SEC filing

Offering details

Securities
Debt, Option to acquire
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-302891

Source: Form D, filed Jan 8, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Richard A. Andrews Director
Douglas C. Hixson Director
Richard G. Horan Director
Pierre Laurin Director
Yow Pin Lim Director, Executive
Denice Spero Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
349 Eddy Street
Providence, RI, 02903